Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents

Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age1-18
SponsorXiaofan Zhu

About this trial

Fanconi anemia is a rare autosomal or sex linked recessive genetic disease. The disease is characterized by bone marrow hematopoiesis failure, multiple congenital abnormalities, and susceptibility to neoplastic diseases. The cells of FA patients are extremely sensitive to MMC and DEB. The symptoms and ages of FA patients are different, so by comparing the exome of FA patients and their parents, the mutations that were accumulated in FA patients could be found, and these genes might be sensitive to repairment and be important for hematopoiesis maintainance.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • human whole exome
  • whole genomic

Treatment groups

No treatment groups listed

Sponsors and collaborators

Xiaofan Zhu

Lead sponsor

Chinese Academy of Medical Sciences

Sponsor institution